Stay updated on ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Sign up to get notified when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.

Latest updates to the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page
- ChecktodayChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page has undergone significant content removal regarding the details of an open-label Phase 1/2a study for multiple myeloma, including specific treatment regimens and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference34%
- Check22 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check58 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check79 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
Stay in the know with updates to ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM
Enter your email address, and we'll notify you when there's something new on the ANCHOR Clinical Trial: Melflufen+Dex+Bortez/Dara in RRMM page.